TW200480B - - Google Patents

Download PDF

Info

Publication number
TW200480B
TW200480B TW81102161A TW81102161A TW200480B TW 200480 B TW200480 B TW 200480B TW 81102161 A TW81102161 A TW 81102161A TW 81102161 A TW81102161 A TW 81102161A TW 200480 B TW200480 B TW 200480B
Authority
TW
Taiwan
Prior art keywords
alkyl
group
formula
compound
hydrogen
Prior art date
Application number
TW81102161A
Other languages
English (en)
Chinese (zh)
Original Assignee
Samdoz Pharmaceutical Factory
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Samdoz Pharmaceutical Factory filed Critical Samdoz Pharmaceutical Factory
Application granted granted Critical
Publication of TW200480B publication Critical patent/TW200480B/zh

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
TW81102161A 1991-03-22 1992-03-23 TW200480B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919106179A GB9106179D0 (en) 1991-03-22 1991-03-22 Improvements in or relating to organic compounds

Publications (1)

Publication Number Publication Date
TW200480B true TW200480B (de) 1993-02-21

Family

ID=10692074

Family Applications (1)

Application Number Title Priority Date Filing Date
TW81102161A TW200480B (de) 1991-03-22 1992-03-23

Country Status (6)

Country Link
BR (1) BR1100237A (de)
GB (1) GB9106179D0 (de)
RU (1) RU2095347C1 (de)
SA (1) SA92130185B1 (de)
TW (1) TW200480B (de)
ZA (1) ZA922071B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2478618C2 (ru) * 2010-03-15 2013-04-10 Закрытое Акционерное Общество "Инфарма" Новое биологически активное соединение n-[3-(4-нитрофениламино)-индол-2-илметилен] аминогуанидина гидрохлорид с противовоспалительной активностью

Also Published As

Publication number Publication date
BR1100237A (pt) 2000-07-25
RU2095347C1 (ru) 1997-11-10
GB9106179D0 (en) 1991-05-08
ZA922071B (en) 1993-09-20
SA92130185B1 (ar) 2006-07-11

Similar Documents

Publication Publication Date Title
KR100198018B1 (ko) 아미노구아니딘
US8835488B2 (en) Opioid receptor ligands and methods of using and making same
NZ204482A (en) Alpha-(3-(omega-aminoalkyl)indol-5-yl)alkanesulphonamides
RU2558328C2 (ru) Производные продукты бензимидазол-4-амида, способы их получения, фармацевтические композиции на их основе и их применение в качестве средств для борьбы с вирусом коксаки
PT87308B (pt) Processo para a preparacao de n-(piridinil)-1h-indol-1-aminas e de composicoes farmaceuticas que os contem
JP4889487B2 (ja) 置換されたピペリジン化合物とその使用方法
JP2835731B2 (ja) ピペリジニル化合物類
JPH07503022A (ja) ピリドン誘導体，その製造方法およびその医薬としての使用
JPH06506442A (ja) １−（４−アシルアミノフェニル）−７，８−メチレンジオキシ−５ｈ−２，３−ベンゾ−ジアゼピン誘導体及びその酸付加塩、それを含む製薬学的組成物及びその製造方法
TW200480B (de)
KR101343399B1 (ko) 통증 치료를 위한 카나비노이드 수용체에 대한 리간드로서의 프롤린 유사체
TW382016B (en) 4-[(thien-2yl)methyl]-imidazole analgesics
JP4021481B2 (ja) 抗ガストリン活性を持つ芳香族酸ジアミド類、その製造法および医薬用途
JPH05500958A (ja) 神経保護剤用イミノメタノジベンゾ（ａ，ｄ）シクロヘプテン誘導体
JP7152479B2 (ja) インドール酢酸類誘導体、その製造方法及び医薬用途
US6037345A (en) Method for inhibiting neoplastic cells and related conditions by exposure to quinazolinedione and pyridopyrimidinedione derivatives
Scovill et al. Primaquine analogs: derivatives of 4-amino-2-methoxyacridine
TW200529820A (en) Chroman derivatives
NO164973B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive gem-dihalo- og tetrahalo-1,2-diamino-4,9,-diaza-dodecaner.
TW464497B (en) Use of unsubstituted and substituted N-(pyrrol-1-yl) pyridinamines as anticonvulsant agents
JP2003506376A (ja) １，２−ジヒドロ−１−オキソ−ピラジノ［１，２−ａ］インドール誘導体
US4619927A (en) Novel nitropyrazinyl- and nitropyridinyl- substituted piperazin-3-one and hexahydro-1H-1,4-diazepin-5-one compounds useful as adjuncts to radiation therapy
CN111825619A (zh) 一种苯并咪唑类衍生物及其用途
JPH06107546A (ja) Ａｄｍ耐性解除剤
WO2016206097A1 (zh) 新的5型磷酸二酯酶抑制剂及其应用